PARAMOUNT BIOCAPITAL ASSET MANAGEMENT
Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new biotechnology and life-sciences companies. The company has a keen eye for finding and developing novel therapeutic medicines that have, in our opinion, significant market potential. It assesses promising drug candidates from around the globe, from academic centers to biotechnology firms to pharmaceutical companies. Once compounds are in-licensed, selected memb... ers of the Paramount BioSciences Executive Team -- each member has significant life sciences industry experience, as described in their bios -- supported by approximately 80 in-house professionals, manages their entire development cycle, supporting all aspects of drug development including manufacturing, formulation, technology transfer, pharmacology, toxicology, clinical development, regulatory, quality assurance, commercialization, and life cycle management. After technologies are in-licensed and management teams are recruited to run portfolio companies built around novel therapeutics, Paramount BioSciences arranges for financing through its affiliate Paramount BioCapital, Inc., a FINRA registered broker-dealer. The affiliateรขโฌโขs financial professionals have experience with securities and corporate transactions, including financings and mergers and acquisitions.
PARAMOUNT BIOCAPITAL ASSET MANAGEMENT
Founded:
2008-06-05
Status:
Active
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
PolyCore Therapeutics
PolyCore Therapeuticsโ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2009-08-20 | CEL-SCI | Paramount BioCapital Asset Management investment in Post-IPO Equity - CEL-SCI | 4.4 M USD |
2007-04-25 | Innovive Pharmaceuticals | Paramount BioCapital Asset Management investment in Venture Round - Innovive Pharmaceuticals | 15 M USD |
2006-06-27 | Genelabs Technologies | Paramount BioCapital Asset Management investment in Venture Round - Genelabs Technologies | 8.3 M USD |
2006-05-03 | Ziopharm oncology | Paramount BioCapital Asset Management investment in Post-IPO Equity - Ziopharm oncology | 37 M USD |
2005-01-12 | Chelsea Therapeutics International | Paramount BioCapital Asset Management investment in Post-IPO Equity - Chelsea Therapeutics International | 14.5 M USD |